MedPath

Early Administration of Intravenous Tranexamic Acid in Acute Gastrointestinal Bleeding Prior to Endoscopy

Phase 3
Conditions
Acute Gastrointestinal hemorrhage.
Gastrointestinal haemorrhage, unspecified
Registration Number
IRCT2014120120178N1
Lead Sponsor
Colorectal Research Center,Rasoul Akram Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
516
Inclusion Criteria

Inclusion Criteria:Chief complaint of hematemesis, melena or hematochezia and objective signs of gastrointestinal bleeding,and age more than 18

Exclusion Criteria

Pregnancy , lactation,Oral Contraceotive Pill users,History of thromboembolic disease(cardiac and/or cerebrovascular thrombotic events,pulmonary thromboembolc eventi,deep vein thrombosis),Malignancy (except those cured and has not recurred more than two years), End stage renal disease and /or Nephrotic syndrome,
Underlying cardiac rhythm disorder where anticoagulation is indicated (e.g. atrial fibrillation/flutter),Signs and symptoms suggestive of clinically significant infectious disease (e.g. body temperature > 38 degree),Acquired color vision impairment, visual loss and retinal venous and arterial occlusions,Past history of seizure ,severe liver disease and/or previous history of variceal bleeding,Cases where informed consent is unobtainable, any allergic history to this medication

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
rgent endosopy rate. Timepoint: ;first endoscopy at less than 24hour after emergency visit. Method of measurement: Time frame as hour.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath